Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Empower Clinic Services, LLC dba Empower Pharmacy
WARNING LETTER
•Empower Clinic Services, LLC dba Empower Pharmacy•August 28, 2024

Empower Clinic Services, LLC dba Empower Pharmacy – FDA Warning Letter, Aug 28, 2024

Record Details

On April 2, 2025, the FDA issued Warning Letter #700962 to Empower Pharma, an outsourcing facility registered under section 503B of the FDCA. The letter followed an inspection from August 1 to August 28, 2024, which revealed serious deficiencies in the production of sterile drug products, putting patients at risk.

The FDA noted that Empower Pharma's drug products, including Pyridoxine HCl (B6) Injection Solution, failed to meet 503B conditions, specifically lacking adverse event reporting information and adequate directions for use on labels. This renders the products ineligible for exemptions from FDA approval, adequate directions for use, and Drug Supply Chain Security Act requirements.

Violations included adulterated drug products due to insanitary conditions and CGMP failures. Examples cited were inadequate product evaluation after microbial contamination in the ISO 5 aseptic area, failure to perform adequate dynamic smoke studies, and lack of appropriate written procedures for preventing microbiological contamination (21 CFR 211.113(b)). The firm also failed to thoroughly investigate discrepancies (21 CFR 211.192), maintain aseptic equipment (21 CFR 211.42(c)(10)(vi)), monitor environmental conditions (21 CFR 211.42(c)(10)(iv)), and establish adequate production and process controls (21 CFR 21

Company
Empower Clinic Services, LLC dba Empower Pharmacy
Inspection date
August 28, 2024
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • F. Gail Bormel (F.)
View Company Profile

ID · 31515f8c-5824-4340-ad9a-24a69b1d4222

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 331(a)21 CFR 211.100(a)21 U.S.C. 331(d)21 CFR 211.113(b)21 U.S.C. 321(p)21 CFR 211.42(c)(10)(iv)21.U.S.C. 355(a)21 U.S.C. 331(k)21 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for Empower Clinic Services, LLC dba Empower Pharmacy
  • WARNING_LETTER - 2025-11-14November 14, 2025
  • WARNING_LETTER - 2024-10-04October 4, 2024
  • WARNING_LETTER - 2020-03-06March 6, 2020

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Empower Clinic Services, LLC dba Empower Pharmacy
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.